Phenethanolamines and uses thereof
CA 1235705 A · Owner: Bristol-Myers Company · Inventors: Temple, Davis L. Jr.; Roth, Herbert R.; Nair, Xina
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
New compositions using particular B2 agonists and vehicle materials have been prepared and are useful for producing a topical anti-inflammatory effect in mammals. The selected B2 agonists have previously not been known to exhibit topical antiinflammatory activity. The compositions can be for example in the form of sprays, ointments creams, gels, lotions, and suppositories all of which are to, be applied to the mammal topically as opposed to, systemically. Also, N-(3-Indolyl-isopropyl)- and N-(3-indolyl-tbutyl)-2-(4-hydroxy-3-methanesulfonamidophenyl)-2hydroxyethylamines and their pharmaceutically accept-. able salts are antiasthmatic agents as demonstrated by bronchodilation action and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 26, 1988. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 26, 2005.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.